Recent discoveries about the interaction of GPER-1 with synthetic and environmental estrogens emphasize the importance of considering the expression and activity of this receptor in the formulation of more effective and specific therapeutic approaches for breast cancer, establishing an additional link that strengthens the ability to tailor therapeutic interventions to the specific molecular characteristics of each patient. This evidence concerns the gene GPER1 and breast carcinoma.